INTRODUCTION
With the remarkable development of sequencing technology, the genomes of diverse species from bacteria to human have been completely sequenced. The identification of unknown organisms via genome-sequencing analyses has also been rapidly performed as soon as the species are discovered (Pagani et al., 2012) . In addition, sequencing speed has been greatly accelerated by the recent advent of next-generation sequencing (NGS) methods, which appeared in the last decade following the conventional, capillary-based sequencing methods. NGS methods analyze various sizes and types of DNA libraries more accurately, rapidly, and cheaply in a highthroughput fashion (Mardis, 2011; Metzker, 2010; Pareek et al., 2011; Shendure and Lieberman Aiden, 2012; Soon et al., 2013; Zhang et al., 2011) . NGS provides powerful tools, not only to discover fundamental biological information, such as wholegenome sequences, variations, and DNA-protein interactions, but also to apply to diagnostics and clinical uses (Encode Project Consortium et al., 2012) . For instance, the first human genome projects required 10 years and 3 years for sequencing and analysis, respectively; whereas current NGS technology allows the sequencing of multiple human genomes in a single run, requiring only a single week and reagent cost of less than $5,000 per genome (Lander et al., 2001; Soon et al., 2013; Venter et al., 2001) .
The genome sequences contributed tremendously to all bioscience-related studies across biochemistry, agriculture, bioen-gineering, and medicine, as well as to the bioindustrial production of value-added products such as platform chemicals (Du et al., 2013; Esvelt and Wang, 2013; Heitzer et al., 2013; Reyes et al., 2012; Shokralla et al., 2012) . However, the genome sequences did not merely make contributions to the deeper understanding of the molecular mechanisms of cellular function; they also provided engineering targets for various genomemanipulation technologies such as zinc-finger nuclease (ZFN) and transcription activator-like effector nucleases (TALENs) (Bedell et al., 2012a; Cong et al., 2013; Jiang et al., 2013; Kim et al., 2012a; Mali et al., 2013; Wang et al., 2012a) . These recent breakthroughs in genome-engineering technologies are now offering new opportunities to produce rationally designed biological functions, which are critical issues that should be addressed by synthetic biology.
A major objective of synthetic biology is the design and engineering of biologically based parts, novel devices, and systems, as well as the redesign of existing biological systems (Endy, 2005; Nandagopal and Elowitz, 2011; Pleiss, 2006) . A wide range of biological systems can be engineered to add new functions or to edit existing functions according to a user's purpose in a modular, reliable, and predictable way. This is possible because biological functions are inherently expressed through proteins and RNAs that are primarily encoded in DNA sequences. In addition, biological regulatory elements such as logic gates, feedback systems, and oscillators can be defined (Khalil and Collins, 2010) . Thus, synthetic biology has great potential to deliver important new applications and improve existing industrial processes across many sectors including energy, pharmaceuticals, and materials (Martin et al., 2009; Medema et al., 2011; 2012) . Here, we review the emerging tools currently available for synthetic biology that can be integrated to design and build novel biological systems. The future perspective of this new, emerging field is also discussed.
tion. The advent of new technology for high-throughput DNA sequencing, NGS, overcame these barriers and caused a revolution in genome science.
Currently, three representative sequencers with different platform technologies are commercially available. The first commercial NGS platform was the Roche 454 System based on 'pyrosequencing'. Instead of sequencing in multiple tubes or microplate wells, the DNA library is amplified by emulsion polymerase chain reaction (PCR) on the surfaces of hundreds of thousands of beads (Dressman et al., 2003; Margulies et al., 2005) . The current GS FLX+ system can sequence about 500 Mb of raw sequence in 23 h with a consensus accuracy of 99.99% and an average read length of 1,000 bp. Compared with other sequencing platforms, the Roche 454 system has an advantage in mapping repetitive regions because of its longer read length; but it has the disadvantage of an increasing error rate when sequencing a homopolymer: a row of repeats of the same short sequence (Rothberg and Leamon, 2008) . The second commercial platform, the Illumina Genome Analyzer, is based on sequencing by synthesis and emerged in 2006. Different from the method using micro-beads mentioned above, the adaptor-linked DNA library binds to complementary adaptors immobilized in a flow cell and forms clusters via bridge amplification (Adessi et al., 2000) . The clustered library produces a signal by incorporating four differentially labeled fluorescent dNTPs, and the sequencing progresses by repeating the process. The HiSeq 2,500 system currently produces a maximum read length of two 100 bp paired-end reads in highoutput mode, which results in about 600 Gb of output within 11 days. The MiSeq system, a bench-top sequencer, produces a read length of two 250 bp paired-end reads and a maximum of 8.5 Gb of data per run. The third commercial system, the Sequencing by Oligonucleotide Ligation and Detection (SOLiD) sequencer using the Polonator technology, was commercially released in 2007 (Shendure et al., 2005 . The open-source sequencer uses emulsion PCR, to immobilize the DNA library onto a solid support, and cyclic sequencing-by-ligation chemistry. A recent version, the 5,500 Series Genetic Analysis Systems, can sequence a maximum of 20 Gb of DNA per day. Personal sequencers, such as the MiSeq and Ion torrent™, of small size are efficient for relatively fast analyses. The difference of the Ion torrent™ system compared with other sequencing techniques is the use of a semiconductor-based sequencing technique rather than signal detection methods, such as the use of fluorescent dyes. In this system, when a dNTP is incorporated into DNA, it produces a pyrophosphate and a proton. The DNA library is immobilized in microwells, and when a dNTP is incorporated into the DNA by DNA polymerase, the change in pH caused by the protons can be detected as a voltage change. Sequencing data can be obtained rapidly and at low cost, because the Ion torrent™ system does not use expensive dNTPs labeled with fluorescent dyes and an optical detection device. The Ion PGM sequencer produces a maximum read length of 400 bp and generates between 1 and 2 Gb of data within several hours. The maximum read length and the total output of each platform is continuously increasing.
Unlike the NGS platforms that depend on DNA-library amplification, third-generation sequencing platforms determine DNA sequences directly from a single DNA molecule (Pareek et al., 2011; Schadt et al., 2010) . This single-molecule sequencing can overcome sequencing errors and biases, caused by the favor of certain sequences during the amplification step, that potentially distort the abundances of various DNA fragments in the sample. These novel methods rely on sequencing by syn-thesis, sequencing by degradation, or sequencing by direct physical inspection of the DNA molecule via a specially engineered DNA polymerase, various artificial nanopores, or advanced microscopy techniques (Clarke et al., 2009; Zhang et al., 2011) . Although most third-generation sequencing platforms are currently still in development, they will offer advantages over current technologies, such as higher throughput, faster turnaround time, longer read lengths, higher accuracy, smaller amounts of starting material, and lower sequencing costs (Schadt et al., 2010) .
Genome sequencing
With its high accuracy, fast speed, and low cost, NGS is widely used to determine the genome sequences of various organisms and the variations between genome sequences (Pushkarev et al., 2009; Wheeler et al., 2008) . As of June 2012, a total of 3920 bacterial genomes and 854 eukaryotic genomes have been completely sequenced (Pagani et al., 2012) . In addition to routine de novo genome sequencing, NGS can be also used for the diagnosis and monitoring of pathogens including viruses, bacteria, fungi, and parasites. NGS can produce full information about the genotype of a pathogen within several hours and help to formulate a drug for an unknown pathogen as soon as possible for public health purposes. NGS could replace complicated and time-consuming techniques used in routine clinical microbiology practices with a simple, more efficient workflow (Didelot et al., 2012; Shendure and Lieberman Aiden, 2012; Soon et al., 2013) .
The obvious applications of NGS are de novo genome sequencing, whole-genome resequencing, and targeted resequencing. The first application of NGS to genome sequencing was to elucidate Acinetobacter baumannii pathogenesis using 454 sequencing technology (Smith et al., 2007) . Despite the sequencing power of NGS, the short reads obtained from NGS draw a setback in terms of genome assembly and mapping applications (Wold and Myers, 2008) . For example, repetitive sequences are widely distributed across the entire human genome, therefore the short reads are placed equally at multiple chromosomal locations. Efforts in bioinformatics have been made to overcome the limitation; but many challenges still exist to either efficiently assemble short reads de novo or else align them to a reference genome. The currently available bioinformatics tools for short-read alignment and de novo and reference-guided assembly have been reported elsewhere (Martin and Wang, 2011; Zhang et al., 2011) .
Nevertheless, NGS allows for very deep genomic coverage. Whole-genome resequencing is therefore being widely performed for the correct identification of SNPs and structural variations such as insertions, deletions, copy number variations, and rearrangements. For example, a large number of human genomic variations have been determined by multi-institute consortia projects (1000 Genomes Project Consortium et al., 2010 Ball et al., 2012; Encode Project Consortitum, 2012; Hugo Pan-Asian SNP Consortium et al., 2009) . To date, more than 30 million SNPs have been discovered by human genome sequencing projects. Copy number variation has also been shown to be associated with various diseases including glomerulone-phritis (Aitman et al., 2006) and Crohn's disease (McCarroll et al., 2008) . Resequencing can also be applied to sequence an entire bacterial genome to identify acquired mutations. For instance, accumulated mutations in microbes adaptively evolved in the laboratory have been detected by comparing polymorphisms between ancestral and evolved genomes (Araya et al., 2010; Atsumi et al., 2010; Charusanti et al., 2010; Conrad et al., 
